BehaveNet^®
Clinical Capsule™

Join Our Mailing List

For Email Newsletters you can trust

Movies

Facebook

Twitter

drug:

paliperidone

Clinical class	atypical antipsychotic, neuroleptic
Action	dopamine type 2 and serotonin type 2 antagonist
Chemical class	benzisoxazole derivative
CSA schedule	none
DEA number
NDC
Routes of administration	oral (OROS^®)
Associated with (substance-related)	disorders: none
Availability	prescription

MEDLINEplus^® Drug Information

U.S. Preparations:

Invega^® (Janssen) FDA approved for:
12.19.2006 acute maintenance and treatment of schizophrenia in adults; acute treatment of schizoaffective disorder as monotherapy; acute treatment of schizoaffective disorder as an adjunct to mood stabilizers and/or antidepressants
US prescribing information
Invega^® Sustenna™ (Janssen) FDA approved for:
7.31.2009 acute maintenance and treatment of schizophrenia in adults
US prescribing information

http://www.behavenet.com/capsules
Search Capsules™ | Terms of Use | Request New Term
Capsules™ Copyright © 1997-2010 BehaveNet®